Projection of global revenue for orphan prescription drugs 2010-2024

The data displays the worldwide revenue generated through prescription orphan drugs from 2010 to 2024. In 2014, orphan drugs revenues totaled 94 billion USD. Orphan drugs are used to target rare diseases or disorders, which in the U.S. is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the U.S. through the Orphan Drug Act of 1983.